헤모네틱스 (HAE) 주가

헤모네틱스(HAE)는 NYSE에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $108.61 (+0.94%), 시가총액 $2.71B, PER (주가수익비율) 29.05, 52주 최저~최고 $47.67 ~ $87.16.

Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 tools. It also provides treatment in electrophysiology, critical care, neurocritical care, trauma, burn surgery, spine surgery, and cancer surgery; SavvyWir

핵심 지표

• 현재가: $108.61 (+0.94%)
• 시가총액: $2.71B
• PER (주가수익비율): 29.05
• 52주 최저~최고: $47.67 ~ $87.16
• 섹터: Healthcare
• 산업: Medical Devices
• 거래소: NYSE

헤모네틱스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

헤모네틱스 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 3.40
• 순이익률: 0.07%
• 영업이익률: 0.15%

자주 묻는 질문